Pippa Pessary Study (Clinical Trial)

Inclusion Criteria: * Female, ≥18 years of age * Diagnosed with SUI by a physician using a cough stress test (positive test) * Confirmed Pippa Fitness Pessary fit in clinic by a physician or qualified clinician (e.g., Nurse Practitioner, Registered Nurse) * Have a \>3 month history of experiencing more than 3 episodes of SUI per week * English literacy sufficient to understand the nature of the study and sufficient to read and understand the informed consent form * Provision of a signed and dated informed consent form * Willingness to use the Pippa Fitness Pessary during the study and comply with study procedures * Willingness to forego use of any vaginal insert (e.g.: vaginal pessaries, bladder supports, estrogen rings, tampons, and menstrual cups) while the Pippa Fitness Pessary is in place * Willingness to cease use of any other form of urinary incontinence treatment for the duration of the study * Willingness and ability to interact with study staff by email, phone, text message and video conferencing software throughout study Exclusion Criteria: * Known urethral stricture, bladder neck contracture, spastic bladder, vesicoureteral reflux, bladder stones, and/or bladder tumors * Concurrent bladder specific medications (including beta agonists or anticholinergics) that affect urination and the use of any other prescription medication and/or over-the-counter medication and/or dietary supplements (including herbal supplements and those taken as teas) that affect urination, except in those instances where they are medically necessary and can be actively supported at a stable dosage throughout the active study period * Known prolapse beyond hymen or any POP-Q point \> 0 * Known hypersensitivity to silicone rubber * Pelvic floor surgery including anterior bladder repair and urethral slings * Vaginal, perineal, or uterine surgery, or abortion (spontaneous or induced) within the past 3 months * Any injectable treatments, or prior surgeries for incontinence * Class III Obesity (BMI \> 40.0 kg/m2) * Currently suffering from urinary tract or vaginal infection * Pregnant or planning to become pregnant within 3 months, or within 3 months postpartum * History of Toxic Shock Syndrome or consistent symptoms * Previously diagnosed with urge-predominant or mixed predominant urinary incontinence, functional incontinence, incontinence due to a central or spinal cord neurological condition (such as multiple sclerosis, neurogenic bladder, Parkinson's, spina bifida), insensate incontinence, or overflow incontinence * Screening laboratory values outside the reference range considered significant by the investigator which might impact the safety of the participant or outcome of the study * Unsuccessful fit assessment during screening * Any other reason the investigator decides the potential participant should not participate in the study * Self-reported difficulty emptying bladder * Difficulty inserting or wearing an intra-vaginal device